Anna M. Stevens

3.1k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Anna M. Stevens is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Anna M. Stevens has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Anna M. Stevens's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Anna M. Stevens is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Anna M. Stevens collaborates with scholars based in United States, Belgium and Rwanda. Anna M. Stevens's co-authors include William C. Stallings, Roderick A. Stegeman, Ravi G. Kurumbail, James K. Gierse, Joseph J. McDonald, Peter C. Isakson, Karen Seibert, Thomas D. Penning, Michael S. South and John J. Parlow and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and American Journal of Ophthalmology.

In The Last Decade

Anna M. Stevens

25 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1996 1.6k citations Ravi G. Kurumbail, Anna M. Stevens et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna M. Stevens United States	16	1.2k	1.0k	617	320	224	26	2.5k
Roderick A. Stegeman United States	18	1.2k 1.0×	1.0k 1.0×	825 1.3×	356 1.1×	230 1.0×	29	2.7k
Joseph J. McDonald United States	20	1.4k 1.2×	1.1k 1.1×	911 1.5×	385 1.2×	283 1.3×	38	2.9k
Michael G. Malkowski United States	33	1.1k 0.9×	630 0.6×	1.4k 2.3×	379 1.2×	330 1.5×	75	3.5k
Jean‐Pierre Falgueyret Canada	32	833 0.7×	960 1.0×	1.4k 2.2×	282 0.9×	287 1.3×	73	3.0k
Thomas D. Penning United States	24	1.2k 1.0×	1.5k 1.5×	1.2k 2.0×	346 1.1×	235 1.0×	52	3.4k
M. David Percival Canada	36	796 0.7×	638 0.6×	1.4k 2.2×	316 1.0×	242 1.1×	68	3.1k
Brad R. Henke United States	24	423 0.4×	685 0.7×	2.3k 3.8×	446 1.4×	338 1.5×	39	3.3k
Paul Hadváry Switzerland	25	620 0.5×	372 0.4×	1.2k 1.9×	106 0.3×	149 0.7×	45	2.8k
Brian K. Hubbard United States	35	1.1k 0.9×	595 0.6×	2.4k 3.9×	188 0.6×	541 2.4×	78	4.5k
Maria Giovanna Chini Italy	26	394 0.3×	526 0.5×	1.0k 1.7×	160 0.5×	98 0.4×	86	2.2k

Countries citing papers authored by Anna M. Stevens

Since Specialization

Citations

This map shows the geographic impact of Anna M. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Stevens more than expected).

Fields of papers citing papers by Anna M. Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Stevens. The network helps show where Anna M. Stevens may publish in the future.

Co-authorship network of co-authors of Anna M. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Stevens. A scholar is included among the top collaborators of Anna M. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Stevens. Anna M. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stevens, Anna M., et al.. (2024). Mesenchymal stem cells enhance targeted bone growth from injectable hydrogels with BMP‐2 peptides. Journal of Orthopaedic Research®. 42(7). 1599–1607. 8 indexed citations

Kestelyn, Philippe, et al.. (2017). Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients. Investigative Ophthalmology & Visual Science. 39(1). 105–109.

Stevens, Anna M., Philippe Kestelyn, Dirk De Bacquer, & Philippe Kestelyn. (2012). Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial. Acta Ophthalmologica. 90(3). e221–4. 51 indexed citations

Schweitzer, Barbara A., William L. Neumann, Gennadiy Poda, et al.. (2005). Structure-based design and synthesis of pyrazinones containing novel P1 ‘side pocket’ moieties as inhibitors of TF/VIIa. Bioorganic & Medicinal Chemistry Letters. 15(12). 3006–3011. 13 indexed citations

Hallinan, E. Ann, Timothy J. Hagen, William M. Moore, et al.. (2004). 5-Fluorinated l-Lysine Analogues as Selective Induced Nitric Oxide Synthase Inhibitors. Journal of Medicinal Chemistry. 47(4). 900–906. 16 indexed citations

South, Michael S., Brenda L. Case, Darin E. Jones, et al.. (2003). Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. Bioorganic & Medicinal Chemistry Letters. 13(14). 2319–2325. 32 indexed citations

Parlow, John J., Ravi G. Kurumbail, Roderick A. Stegeman, et al.. (2003). Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex. Bioorganic & Medicinal Chemistry Letters. 13(21). 3721–3725. 19 indexed citations

South, Michael S., Thomas Girard, Rhonda M. Lachance, et al.. (2003). Polymer-Assisted solution-Phase (PASP) parallel synthesis of an α-Ketothiazole library as tissue factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(14). 2363–2367. 15 indexed citations

Hallinan, E. Ann, Steven W. Kramer, William M. Moore, et al.. (2003). 4-Fluorinatedl-lysine analogs as selective i-NOS inhibitors: methodology for introducing fluorine into the lysine side chain. Organic & Biomolecular Chemistry. 1(20). 3527–3534. 37 indexed citations

10.

Gierse, James K., Ravi G. Kurumbail, Mark C. Walker, et al.. (2002). Mechanism of Inhibition of Novel Cox-2 Inhibitors. Advances in experimental medicine and biology. 507. 365–369. 6 indexed citations

11.

Feng, Yiqing, John J. Likos, Leiming Zhu, et al.. (2002). Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1598(1-2). 10–23. 91 indexed citations

12.

Kiefer, James R., Jennifer L. Pawlitz, Kirby T. Moreland, et al.. (2000). Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature. 405(6782). 97–101. 212 indexed citations

13.

Barta, Thomas E., Daniel P. Becker, Louis J. Bedell, et al.. (2000). Synthesis and activity of selective MMP inhibitors with an aryl backbone. Bioorganic & Medicinal Chemistry Letters. 10(24). 2815–2817. 21 indexed citations

14.

Freskos, John N., et al.. (1999). Synthesis and identification of conformationally constrained selective MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(13). 1757–1760. 24 indexed citations

15.

Stevens, Anna M., Jennifer L. Pawlitz, Ravi G. Kurumbail, et al.. (1999). Crystallization of recombinant cyclo-oxygenase-2. Journal of Crystal Growth. 196(2-4). 350–355. 4 indexed citations

16.

Kurumbail, Ravi G., Anna M. Stevens, James K. Gierse, et al.. (1996). Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 384(6610). 644–648. 1559 indexed citations breakdown →

17.

Shieh, Huey‐Sheng, Ravi G. Kurumbail, Anna M. Stevens, et al.. (1996). Three-dimensional structure of human cytomegalovirus protease. Nature. 383(6597). 279–282. 119 indexed citations

18.

Hanson, Gunnar J., Michael Clare, Neena L. Summers, et al.. (1994). Renin inhibitor SC-51106 complexed with human renin: Discovery of a new binding site adjacent to P3. Bioorganic & Medicinal Chemistry. 2(9). 909–918. 8 indexed citations

19.

Kestelyn, Philippe, H Taelman, Jos Bogaerts, et al.. (1993). Ophthalmic Manifestations of Infections with Cryptococcus neoformans in Patients with the Acquired Immunodeficiency Syndrome. American Journal of Ophthalmology. 116(6). 721–727. 59 indexed citations

20.

Kestelyn, Philippe, Jos Bogaerts, Anna M. Stevens, Peter Piot, & A Meheus. (1989). Treatment of Adult Gonococcal Keratoconjunctivitis with Oral Norfloxacin. American Journal of Ophthalmology. 108(5). 516–523. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact